We’ve known for a long time that there was more going on than the extra wear and tear caused by extra weight in arthritis. Metabolic syndrome, a situation that can result from high-sugar and carbohydrate diets, lack of exercise, stress, lack of sleep, and sometimes genetics is also a huge factor in the breakdown of joints as well as many other serious health risks. What does the fat stem cell secreted protein called adiponectin have to do with this? Let take a look…
Osteoarthritis is a degenerative disease that affects not just the joint-protecting cartilage but can also be associated with pain, stiffness, and bone issues, such as bone spurs that form to address instability or bone marrow lesions (BMLs) that occur in the subchondral (beneath the cartilage) bone, particularly common in hip arthritis. It’s also interesting to note that arthritis can really present as an entirely different disease depending on the joint involved. For example, knee arthritis and hip arthritis are much different diseases based on a variety of things, such as speed of progression, formation of bone cysts, ability of the joint to self-maintain, and so on (if you want to learn more about this, watch my short video below).
While arthritis can be genetic, there are often external factors at play in arthritis as well, such as obesity, previous injuries, and so on. Osteoarthritis is also the number-one reason why patients undergo joint replacements!
Now, a new study suggests that the protein adiponectin may be one indicator of arthritis.
Adiponectin is the most abundant protein secreted into our blood serum by our fat (adipose) cells, specifically those in our white fat tissue. Previous studies have shown benefits to the adiponectin protein in the blood, such as a decreased risk of atherosclerosis and heart attack as well as a reversal of insulin resistance and type-2 diabetes. Low adiponectin levels, it has recently been suggested, may actually be an indicator of metabolic disease. So normal levels of adiponectin seem to be a good thing. Unfortunately, however, our understanding of the fat arthritis connection just became clearer as there seems to be a very fine balance here as excess concentrations of adiponectin in the blood may come with a sacrifice—our joints. Let me explain.
According to today’s focus study, previous studies have made a variety of conflicting associations between adiponectin and osteoarthritis. For example, in one, increased inflammatory markers (e.g., interleukin 6) were found when cartilage cells were treated with adiponectin (suggesting eventual cartilage breakdown and arthritis). In another, excess amounts of adiponectin were found in the synovial fluid (the fluid that lubricates the joints). In yet another, no association was made between adiponectin and arthritis, while another found a benefit to joints with increased concentrations of adiponectin.
All of these conflicting findings regarding the fat arthritis connection motivated researchers to complete a new study using a meta-analysis (an aggregate of many studies) of thirteen studies to investigate whether or not an actual association existed between adiponectin and arthritis. The final result? Adiponectin levels were found to be higher in those with arthritis than in those without, leading researchers to conclude that there may indeed be an association between those high adiponectin concentrations and the occurrence of arthritis. These findings were especially pronounced in late-stage arthritis and in knee arthritis.
Adiponectin is only one of many potential connections to arthritis. Take a look at a few other associations that have recently be found:
The upshot? What do these new fat arthritis connection findings mean? We’ll see what the future holds, and whether they may factor into early diagnosis or be a target for treatment. What we do know is the causes of arthritis are many. Some of which are genetic, some of which can be controlled by lifestyle choices, and some by treatment. Do what you can on your end, and we’re here to help on the treatment end!
About the Author
Christopher J. Centeno, M.D. is an international expert and specialist in regenerative medicine and the clinical use of mesenchymal stem cells in orthopedics. He is board certified in physical medicine as well as rehabilitation and in pain management through The American Board of Physical Medicine and Rehabilitation.…